Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation. | Semantic Scholar
PFS (A) and OS (B) comparing R-DA-EPOCH and R-CHOP regimen in 26 cases... | Download Scientific Diagram
Double hit and double expressors in lymphoma: Definition and treatment - Riedell - 2018 - Cancer - Wiley Online Library
How should we treat double hit and double expressor lymphomas?
Double-Expressor Phenotype (BCL-2/c-MYC Co-expression) of Diffuse Large B-Cell Lymphoma and Its Clinicopathological Correlation | Article - Cureus
Frontiers | Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC/BCL2 double expressor lymphoma
Double hit lymphoma: How do we define it and how do we treat it? - ScienceDirect
Progression-free survival comparing double-hit lymphomas to... | Download Scientific Diagram
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements | Haematologica
Outcomes of patients with double/triple expressor diffuse large B-cell lymphoma (DLBCL) treated with R-DA-EPOCH/R-CHOP: A single-center experience. - ScienceDirect
Progression-free survival (PFS) curves (A) and overall survival (OS)... | Download Scientific Diagram
Diffuse Large B Cell Lymphoma:
Kaplan-Meier curves of progression-free survival and overall survival.... | Download Scientific Diagram
Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival | SpringerLink
Diffuse Large B Cell Lymphoma:
Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma | Diagnostic Pathology | Full Text
Cancers | Free Full-Text | The Incidence and Treatment Response of Double Expression of MYC and BCL2 in Patients with Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma | Leukemia
How should we treat double hit and double expressor lymphomas?
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation. | Semantic Scholar
Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma - Biology of Blood and Marrow Transplantation
Dr. Sarah Rutherford Sheds Light on Double-Hit, Double-Expressor Lymphomas – New Developments in Lymphoma
Patterns of Failure in Patients With Double Hit or Double Expressor Lymphomas: Implications for Radiation Therapy - ScienceDirect
Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma | Modern Pathology
